ClinicalTrials.gg
Not yet recruitingNCT07766928Updated Aug 17, 2026

Lipid and Glucose Response to Plant-based and Regular Burgers

An interventional study of Acute consumption of different burger types in Metabolic Syndrome, sponsored by University of Saskatchewan. Not yet recruiting at 1 site in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-17.

Sponsored by University of Saskatchewan · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study evaluates the blood lipid and glucose response to two burgers: 1) A plant-based meat alternative burger and 2) a regular beef burger in a cross-over trial.

Read the detailed description

Postprandial blood lipids and glucose are risk factors for cardiovascular disease. This study evaluates the postprandial response to consuming a plant-based meat-alternative burger and a regular beef burger. Ten participants will consume each burger on separate days. Blood lipids, glucose, and blood pressure will be assessed for six hours after each condition.

02

Conditions studied

  • Metabolic Syndrome

Browse trials for

03

In context

Metabolic Syndrome

2,116 studies on the registry are indexed under Metabolic Syndrome; 347 are open to participants now.

This study's planned enrollment of 10 is below the median of 60 across 1,572 interventional studies indexed under Metabolic Syndrome.

Browse Metabolic Syndrome studies →

Lead sponsor

University of Saskatchewan is the lead sponsor of 243 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 25 or higher

Exclusion criteria

Exclusion Criteria:

  • Not diagnosed with diabetes
  • Not on any medications for glucose or lipids
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    Plant-based burger

    Plant-based meat alternative burger

    Dietary Supplement: Acute consumption of different burger types

  • Experimental
    Beef burger

    Regular beef burger

    Dietary Supplement: Acute consumption of different burger types

Interventions

  • Dietary supplementAcute consumption of different burger types

    Consumption of beef (animal-based) vs pea (plant-based) burgers

06

What researchers measure

Primary outcomes

  1. Change in triglycerides (mmol/L)

    Blood measure of triglycerides

    Time frame: 6 hours

Secondary outcomes

  1. Change in glucose (mmol/L)

    Blood measure of glucose

    Time frame: 6 hours

  2. Change in cholesterol (mmol/L)

    blood measure of cholesterol

    Time frame: 6 hours

  3. Change in high density lipoprotein (mmol/L)

    blood measure of high density lipoprotein

    Time frame: 6 hours

  4. Change in low density lipoprotein (mmol/L)

    blood measure of low density lipoprotein

    Time frame: 6 hours

  5. Change in systolic blood pressure (mmHg)

    systolic blood pressure measured with a sphygmomanometer

    Time frame: 6 hours

  6. Change in diastolic blood pressure (mmHg)

    diastolic blood pressure measured with a sphygmomanometer

    Time frame: 6 hours

07

Study locations

1 site
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07766928
Responsible party
Phil Chilibeck (Professor, University of Saskatchewan) — Principal investigator
First posted
Aug 17, 2026
Start date
Aug 17, 2026 (estimated)
Primary completion
Sep 30, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Aug 17, 2026

Study contacts

PHILIP Chilibeck, PhD
Contact
phil.chilibeck@usask.ca
3062303849
PHILIP Chilibeck, PhD
principal investigator · University of Saskatchewan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion